Remove AFIB Remove Arrhythmia Remove Atrial Fibrillation
article thumbnail

AFib Might Be Far More Common Than We Think

CardiacWire

A JACC study suggests that atrial fibrillation is far more prevalent than many previously thought, estimating that nearly one in 20 American adults have been diagnosed with the disease. age, 54% women, 50% White), finding that a whopping 2M (6.8%) of them had been diagnosed with AFib. adults would have AFib by 2020.

AFIB 105
article thumbnail

Lifestyle & risk factor changes improved AFib symptoms, not burden, over standard care

American Heart News - Heart News

Research Highlights: A clinical trial with adults who have atrial fibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they received standard care.

AFIB 52
article thumbnail

Five facts about atrial fibrillation

Medical Xpress - Cardiology

Atrial fibrillation, or AFib, is a fast and irregular heart rhythm that, left untreated, can lead to blood clots, stroke and heart failure. It's the most common type of arrhythmia, a potentially serious condition in which the heart beats too quickly, too slowly or in an irregular pattern.

article thumbnail

Colchicine Not the Answer for Recurring Arrhythmias After Ablation

Med Page Today

(MedPage Today) -- For patients undergoing catheter ablation for atrial fibrillation (Afib), there was no signal that a brief course of colchicine reduced atrial arrhythmia recurrence or improved clinical outcomes when taken for 10 days starting.

article thumbnail

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

DAIC

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. 1 Approximately 33 million patients worldwide are living with AFib.

article thumbnail

AI-Guidance Boosts Arrhythmia Ablation Success in Persistent Cases

Med Page Today

(MedPage Today) -- BOSTON -- For persistent atrial fibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after one procedure regardless of antiarrhythmic.

article thumbnail

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

DAIC

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. Food & Drug Administration ( FDA ).